报价延迟最少15分钟:2025/07/20 19:25 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
1.32 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-2.51/-1.25
|
|
企业价值
13.50M
|
| 资产负债 |
|
每股账面净值
-0.42
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
8.51M
|
|
每股收益
0.28
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟：2025/07/20 19:25 EDT
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry. |
